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Summary: The evolution of clinical enzymology is discussed in relation to the history of general enzymology and
clinical chemistry. The discussion is limited to the period from 1835 (definition of catalysis by Berzelius) to 1935
(description of the optical test by Warburg). In conclusion, a general account is given of the introduction of the
concept of quantitative enzyme activity determination into clinical medicine.
Die Entwicklung der klinischen Enzymologie
Zusammenfassung: Die Entwicklung der Klinischen Enzymologie wird vor dem Hintergrund der Geschichte der All-
gemeinen Enzymologie sowie der Klinischen Chemie dargestellt. Die Schilderung beschränkt sich auf den Zeitraum
von 1835 (Definition des Begriffes Katalyse durch Berzelius) und 1935 (Beschreibung des optischen Tests durch
Warburg). Abschließend wird die Rezeption des Konzeptes quantitativer Enzymaktivitätsbestimmungen durch die
Klinische Medizin unter allgemeinen Gesichtspunkten besprochen.
Introduction
Hugo Theorell, at the 3rd International Congress of
Clinical Chemistry in Stockholm 1957, remarked on the
use of enzyme reactions in clinical chemistry: "... The
development has been rather slow until a few years ago;
if I may borrow an expression from bacteriology we
may say that it remained in its "lag phase" for many
years. Now we have obviously come to the "log phase"
(1)". This remark characterizes very well the develop-
ment of clinical erizymology, which today, after a truly
logarithmic growth, plays a central part within clinical
chemistry. The following is an attempt to describe the
historical development of clinical enzymology. I shall
confine myself to that "lag phase", which is approxi-
mately the period from 1835 to 1935, marked by Ber-
zelius' definition of catalysis (2) and by Warburg's work
on cell enzymes (3).
Milestones in the History of Enrymology
First it would be desirable to cast a glance at the history
of general enzymology. Various descriptions by com-
petent authors are available on this subject (4). So it
will suffice here to recall some of the milestones of
development.
The problems of fermentation had been studied since
the antiquity. But only the revolution of chemistry,
initiated by Lavoisier and his contemporaries, gave
prominence to the anomaly of such processes which
did not seem subject to the laws of stoichidmetry.
With the farsighted creation by Berzelius of the term
catalysis (1836) (2), there emerged a new paradigm as
defined by T. S. Kühn (5). Table 1 summarizes the
experimental facts that Berzelius proceeds from. Liebig
Tab. 1. Berzelius (1835) "catalytic force" and "catalysis".
Definition (2)
"Materials act by their mere presence .. . not on account of their
chemical affinities . . . without necessarily participating in the
reaction".
1) Presented at the Symposium on History of Clinical Chemistry,
3r<1 European Congress of Clinical Chemistry, Brighton,
6-6-1979.
Experimental facts
C G. S. Kirchhoff(\*\2)
H.Davy (1817)
L.J. TlienarddSlZ)
J. W. Döbereiner (l 823)
E. Mitscherlich (1834)
Acid hydrolysis of starch (67)
Oxidation of alcohol and ether by
platinum (68)
Decomposition of H2Ü2 (69)
Ignition of H2 in air by platinum
(70)
Formation of ether (71)
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& Wähler, in their description of emulsin, which they
isolated in the following year, made express reference to
Berzelius* definition (6). Shortly before, the investiga-
tion of the digestive process had been initiated by the
studies of Tiedemann & Gmelin (1824) as well as Ebene
(1834). In 1836 Theodor Schwann succeeded in isolating
the first digestive enzyme, pepsin (7) (tab. 2). Alcoholic
fermentation, too, seemed to fit into the pattern created
by Berzelius. By the virtually concurrent yet independent
works (8) of engineer Cagniard de Latour, botanist
Kützing, and physiologist Schwann, yeast was recognized,
in 1837, as a living vegetable organism. There will be no
fermentation of sugar solutions if the access and develop-
ment of "Zuckerpilz" (Schwann (9)) is prevented by
suitable measures.
These findings gave rise to vehement discussions which
continued over the following 35 years and in which
Louis Pasteur intervened from 1837 on (10): On the
one side, the reductionistic thesis, argued mainly by
Liebig (tab. 3), of the chemical action of ferments - on
the other side the thesis, supported with ingenious
experiments by Pasteur, that the action of fermentation
is produced by living cells. This argument, known as the
"Liebig/Pasteur Controversy", certainly delayed the in-
vestigation especially of "soluble ferments" or enzymes,
a term coined by Kühne in 1877.
Tab. 3. Early theories of enzyme action.
1839 Liebig (72) (and Nägeli 1879 (78))
Decomposing ferments act mechanically (state of inner
movement) on other substances
1858 M. Traube (79)
Activation of molecular oxygen
1894 E. Fischer (SO)
Specificity, theory of "lock and key"
1902 W. Osfwald (59)
Enzymes as "biocatalysts"
1903 Henri (62)
1913 Michaelis &Menten (63)
Intermediate complexes with substrate
there were the first signs of a theory of enzyme action
(tab. 3). By the end of century, only a relatively small
number of enzymes had been isolated and more closely
characterized (tab. 4), so that the chemical structure of
enzymes, i.e. their protein nature, was still a matter of
speculation. The proof of this was furnished as late as
in 1926, by Sumner's crystallization of urease (12), a
discovery which introduces the era of modem enzym-
ology.
Tab. 2. Early fundamental work on digestion.
1826 F. Tiedemann &L. Gmelin (72)
Die Verdauung nach Versuchen
1833 W. Beaumont (73)
Experiments and observations on the gastric juice ...
1834 /. N. Ebene (74)
Physiologie der Verdauung, nach Versuchen ...
1836 77z. Schwann (75)
Über das Wesen des Verdauungsprozesses (discovery of
pepsin)
1846 F. Th. Frerichs (76)
Die Verdauung
1852 F. Bidder & C. Schmidt (58)
Die Verdauungssäfte und der Stoffwechsel
This stage of development ended with another change
of paradigm: In 1896 Eduard Buchner detected fer-
mentation by cell-free yeast press juice (11). Meanwhile
Tab. 5. Development of clinical chemistry, (underlined: pupils
of J. Liebig).
Phase Characteristics Figures
Early phase
1840-1860
(1880)
Foundation of
clinical
laboratories
.1880-1932
Beginning of
independence
since 1932
Elementary
analysis.
Animal chemistry
(concept of Liebig
1842)
Development of
methods,
rnicromethods
Colorimetry,
photometry.
Enlarged program:
enzymes,
hormones and
others
Simon
Rees
Bence-Jones
Heller
Scherer
A. Becqtterel
Jaffe
Salkowski
Polin
van Sfyke and
GoldingBird
J. Vogel
Pettenkofer
C. Schmidt
Hoppe-Seyler
Thudichum
Bang
Rona
many others
Tab. 4. Important enzymes known in 19**1 century.
Name
Diastase
Pepsin
Emulsin
Invertase
Urease
Trypsin
Papain
Discovery
#/>c/z/zo//1814(81)
Eberle 1834(74)
Roubiquet et al. 1830 (85)
Dubrunfaut 1846(86)
Fourcroy & Vauquelin 1799 (20)
Owwarf 1857(89)
Hughes SO (92)
Isolation
Payen&Persoz 1833(82)
Schwann 1836(75)
Liebig & Wähler 1837 (6)
£errAe/0M860(87)
M<iCK/w$1876(88)
Kühne 1877(90)
Mtotzetai. 1879(93)
Crystallization
Meyer et al. 1948(83)
Northrop 1930(84)
Sumner 1926 (12)
Northrop ef al. 1931(91)
Balls et al. 1939(94)
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Main Dates of the Evolution of Clinical Chemistry (13)
Before we discuss the development of clinical enzym-
ology, it is necessary to give a brief outline of the essen-
tials of the history of clinical chemistry, in order that
clinical enzymology may be seen in the context of the
historical framework thus created. The central idea of
clinical chemistry, to use changes in the composition of
body materials to diagnose diseases, can be traced far
back in the history of medicine. Appropriate analytical
methods were lacking for a long time. Robert Boyle
(1627-1691) in 1684 was the first to develop a pro-
gram for chemical analysis of blood but it took more
than 150 years to get appropriate analytical methods
for this task. Based on the work of A. L. Lavoisier
(1743—1794), systematic quantitative analysis of
biological materials ("animal chemistry") was started
by Fourcroy (1755-1809) and Berzelius (1779-1848),
improved by Gay-Lussac (1778-1850) and Thenard
and finally perfected by Justus Liebig (1803-1873).
During the third decade of the 19th century the analyti-
cal tools had become available, but doctors were — for
several reasons — not interested in the broad applica-
tion of chemical analysis in practical medicine.
The empirical medicine of the French School, based on
immediate observation, used percussion, auscultation
and anatomic examination, but chemical analysis was
largely absent from diagnosis.
In Germany the situation was quite different due to
the great influence of Schelling's "Naturphilosophie".
Schelling was not antipathetic to chemistry, but trying
to compass all natural phenomena as a whole, he was
more interested in principles than in experimental
details. The medical concepts of this period were
speculative, without close relation to medical practice.
There was no place for results of chemical analyses in
clinical diagnostics.
The swing to the opposite direction — and therefore
the start of clinical chemistry - was brought about
mainly by Justus Liebig*s monograph "Die organische
Chemie in ihrer Anwendung auf Physiologie und Patho-
logie", in April 1842. This book was of particular
significance for the development of clinical chemistry
as it introduced a quantitative method of observation
into physiological chemistry and therefore encouraged
doctors also to apply quantitative analysis to the diagr
nosis of diseases (14). In the meantime ä new scientific-
ally oriented clinical medicine had started to develop,
first of all in France, where the term "physiological
medicine" was coined for it. This way of thinking was
taken up in England1, Austria, and finally in Germany.
Young doctors and chemists — many of them pupils of
Liebig — started chemical investigations in hospitals
(tab. 5).
From a clinical point of view, the results were not very
convincing, the impact on'practical medicine was small,
so basic research came more and more into the fore-
ground from about 1860 onward. It is only around
1880 that clinical chemistry was revived; clinical labo-
ratories then became established and the methodics of
the discipline were expanded systematically.
The stage of independence as a discipline began around
1932 with the publication of the major monograph by
Peters & van Slyke (15). Increasingly, patho-biochem-
istry, too, took its place alongside the development of
methods, although it was only after the second World
War that the number of organizationally independent
clinical chemical laboratories increased world-wide.
Evolution of Clinical Enzymology (16)
Within the historical context already described, how
has clinical enzymology evolved?
The concept of using enzymes as specific reagents for
clinical chemical analyses can be traced far back. In
1780 Francis Home, Professor of materia medica at
Edinburgh, described the fermentation test with yeast
for the detection of glucose in urine (17), a process
that has seen many modifications (e.g. the Einhorn-
Saccharimeter (18), (fig. 1)) and has been used until
recently. Carl Schmidt, in 1850, on the basis of this
principle, carried out very exact determinations of
glucose in blood (19); it then became possible to deter-
mine fasting blood sugar quantitatively for the first
time.
In the examination of urine, the processes of decomposi-
tion (called alkaline and acid fermentation of urine)
Fig. 1. JEY/zAo/TZ-Saccharimeter (from the original publication
(18)). The right part is filled with a mixture of urine and
ca. l g of yeast. After 24 h the CO2 volume shows the
glucose content.
J. Clin. Chern. din. Biochem. /Vol. 19,1981 / No. 8
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attracted early attention. Fourcroy & Vaquelin (20), in
1799, were right in interpreting "alkaline decomposi-
tion'* of urine as a fermentative decomposition of urea.
Only a short time after Schwantfs experiments on
fermentation, these processes were shown to be asso-
ciated with yeast cells identified in microscopic sedi-
ment analyses of decomposing urine samples. In 1860,
Pasteur succeeded in proving that bacteria are the cause
of the alkaline fermentation of urine (21).
The concept, so familiar to us today, of determining
enzyme activities in the blood of patients, was expressed
for the first time by Carl Schmidt, a physiological
chemist of Dorpat (1822-1894) (22). Schmidt was a
pupil of Liebig, Wähler and Rose and later became the
teacher of Wilhelm Ostwald. In 1850, he published a
work on transsudation anomalies (19), fundamental for
early clinical chemistry, in which he reported on some
quantitative tests for the detection of enzymes in blood
(tab. 6) (22). The results of these experiments, however,
were rather poor as the occurrence of bacterial decom-
position led to uncontrolled variations.
Enzyme activities in digestive juices would have been an
obvious choice for investigation after the major works on
the physiology of digestion (tab. 2). Yet clinical chem-
istry was rather hesitant in this area around the mid-19th
century. Although the leading text-books of the new
discipline "Physiological Chemistry", very soon dealt
with digestion at some length (23), decades had to pass
before the diagnostic analyses of digestive juices were
employed in clinical medicine. Methods of clinical
chemical examination for the enzymes of the gastric
and pancreatic juices are first given around 1860, e.g.
by Felix Hoppe f-Seyler) in his "Anleitung zur patho-
logisch-chemischen Analyse" (24). Wilhelm Valentiner
placed more emphasis on the clinical aspects. As an
assistant under v. Frerichs in Breslau and Berlin, Valen-
tiner had learnt how to apply chemical methods in
diagnostics (25). At first, broader application was
faced with practical difficulties such as the obtaining
of gastric juice; the use of emetics was the only method.
With the introduction of the stomach tube (by Leube
Tab. 6. Carl Schmidt 1850.
Charakteristik der epidemischen Cholera gegenüber ver-
wandten Transsudationanomalieen, Leipzig und Mitau
(19), pp. 57 ff.
Typical experiment
l ml blood I ml blood I ml blood I ml blood
0.5 g glucose 0.2 g urea 0.1 g amygdalin 0.1 g asparagin
4 ml water 4 ml water 4 ml water 4 ml water
Incubation at room temperature for about 10 days
Observation of production of
C02 NH3/ HCN
(NH4)2C03
NH3/(NH4)2C03
1871 (26)) for diagnostic purposes, determinations of
enzymes, for the first time, met with greater interest in
clinical medicine. These methods were covered in detail
by the textbooks on clinical diagnostics, which began to
appear from about 1890 (see I.e. (27)). As an example
it suffices to mention the well known German book by
Sahli, Lehrbuch der Klinischen Untersuchungsmethoden
(27). These books show, on the other hand, that the
reception of the enzyme concept by the clinicians is
restricted to digestive enzymes, which are primarily
accessible to the physician.
From the clinical literature of this period it becomes
clear that the concept of catalysis was not accepted by
the clinicians. As late as 1907, the efforts of Heinrich
Schade (1876-1935), later well known for his work on
physical chemistry in internal medicine, to introduce the
concept of catalysis in clinical medicine (28), met with
complete lack of comprehension. The medical faculty
of Kiel University did not accept his book on catalysis
in medicine (29).
In the meantime various enzymes were detected in
blood and urine (30), the usual materials for clinical
chemical examinations. However, the available methods
for determination were much to intricate for clinical
use.
In 1910, Julius Wohlgemuth, then at the experimental-
biological department of the Pathological Institute in
Berlin, proposed a method, worked out by himself a
short time previously, for the determination of amylase
(diastase) in blood and urine for pancreas diagnostics.
He had observed that an occlusion of the ductus pan-
creaticus, both experimentally in animals and in the
patient, results in a strong increase of amylase in the
urine. He says: "After these findings I think it is clearly
indicated that in all future cases with suspected occlu-
sion of the pancreatic duct, the method I have described
should be used to examine the urine for its diastase
content" (31).
Wohlgemuth's method with certain modifications, was
still in use in the nineteen-fifties. We should add that
even now we have not quite reached that target of an
advanced standardized method for amylase. Shortly
afterwards, the determination of lipase in the serum
was added to that of amylase. In 191 I , Peter Rona
(1871-1949), then head of the chemical department
at the hospital "Am Urban" Berlin (32) had developed,
together v/ithLeonor Michaelis, a stalagmometric method
for lipase determination (33) (fig. 2). It is worth noting
that the inhibitors of this enzyme (atoxyl and quinine)
were already employed by Rona (34) for the differentia-
tion of upases from different organs ("atoxyl-resistant
pancreatic lipase").
Rona says in this connection that one should "try to
use this approach for the stepwise elaboratiorxof a kind
of ferment topography, i.e. the determination of the
J. Clin. Chem. Clin..3iochem. / Vol. 19,1981 / No. 8
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origins of individual types of ferments in a mixture of
ferments" (35).
The clinical use of amylase and lipase determinations
for the diagnostics of pancreatic diseases was strongly
advocated by the German clinician Gerhard Katsch
from around 1924 (36). It was he who coined that
easily remembered term, "Fermcntentgleisung" (en-
zyme derailment), for the transition of pancreatic
enzymes into the blood (28).
A new chapter of clinical enzymology was opened with
Archibald Edward Garrocl's epoch-making concept of
the "inborn errors of metabolism", which he presented
in the Croonian Lectures in 1908 (37). However, a
further 40 years were to elapse before the first enzyme
defect of this kind was actually proved (38). An im-
portant enzymological discovery initiated the evolution
of another extensive and clinically important field of
work: In ] 872, Alexander Schmidt, in Dorpat, detected
the "fibrin ferment", later called thrombin (39), thereby
opening the way to the explanation of the coagulation
process. But apart from the bleeding and coagulating
times, it was only the determination of prothrombin
time, described by Quick (40) in 1935, that was used
clinically.
Another stimulus for clinical enzymology came from
quite a different quarter (tab. 7): In 1923, Robert Ro-
bison (1883-1941) had detected * phosphatase which
splits monoesters of phosphoric acid, and which is present
to a large extent in bone (41). Subsequent to this dis-
covery, he developed a theory of ossification (42), which
attracted immediate attention. In 1929,//. D. Kay, who
had previously worked under Robison, reported an
increase of phosphatase in blood plasma in Osteitis
deformans (43), and he described a quantitative method
for determining this enzyme, based on the determina-
tion of the phosphate released from 0-glycerophosphatc
(44). This method was subsequently improved and also
found to be relevant to the diagnostics of liver and bile
duct diseases (45). At first, the method appeared too
complicated from the clinical point of view (46), and
was accepted rather hesitantly by clinical laboratories;
strictly speaking, it was not widely used until after the
second World War. One should not forget, on the other
hand, that this was the first instance where methods for
the determination of alkaline phosphatase were set up
according to advanced criteria which arc valid even today,
i.e. as regards the constancy of the conditions of reac-
tions and the use of the chemically defined substances.
Careful research of the pH optimum of the various phos-
phatases very soon resulted in the delineation of a
specific acid phosphatase in the prostate gland (47)
(tab. 8). Aaron B. Caiman & Ethel B. Gutman (48)
showed, in 1936, that this acid prostatic phosphatase is
also produced in the cells of a prostatic carcinoma and,
in 1938 they demonstrated the transition of this enzyme
into the blood; they therefore succeeded in developing
the first enzymatic method for the diagnosis of car-
cinoma (49). Thus another enzyme activity determina-
tion was introduced to clinical medicine.
Between the first and second World Wars, numerous
attemps were made to use further enzymes for clinical
diagnostics (cf. I.e. (50)). The results of these efforts
were largely unsatisfactory; this was due partly to con-
troversies concerning clinical usefulness, e.g. of the
"Abwehrfcrments" described by Abderhalden (51).
The turning point and the beginning of the present era
of clinical enzymology is marked by a publication which
came out during the second World War and, because of
the war, was hardly taken notice of at the time. In 1943,
Otto Warburg & Walter Christian published a paper on
Tab. 7. Clinical enzymology of alkaline phosphatase.
Early development
1922 R.Robison
(41)
Robison-csicr
Bone phosphata.se, theory of ossification1923 R.Robison
(42)
1929 H. D. Kay (43) Plasma phosphatase in bone diseases
1930 W. M. Roberts Plasma phosphatase in liver-bile diseases
(45)
Activity determination of alkaline phosphatase (44, 45)
]930 Kay
1933 Bodansky
J934 King,
Armstrong
(0-glycerophosphate, pH 7.6)
(0-glyccrophosphate, pH 8.6)
(phenylphosphate, pH 9.3)
(phenolphlhalcin phosphate, pH 9.1 -9.6)1945 Huggins,
Tatalay
1946 ßessey,Lowry, (/7-nilrophcnylphosphate, pH J0.3)
Brock
Tab. 8. Clinical cnzymology of acid phosphatase.
Early development
1934 Bamann, Phosphatascs with different pH
Riedel (47) optimum
1935 Kutscher, High acid phosphatase activity in
Wolbergs (47) prostate
1936 Gutman,Sprout, Synthesis of acid phoxph. tase in
Gutman (48) prostatic carcinoma cells
1938 Gutman, Acid phosphatase in plasma increased
Gutman (49) in prostatic carcinoma
Activity determination of acid phosphatase
1938/40 Gutman, (phenylphosphate, pH 4.9)
Gutman (95)
1945 Muggins, (phenolphthalein phosphate» pH 5.75)
Talatay (45)
1947/48 Abul-Fadl, (inhibition of prostalic enzyme by
King (96) £-tartratc)
1953 Fishman, (specific determination of proslatic
Lerner (97) enzyme by means of £-tartralc)
J. din. Chcm. Clin. Biochem. / Vol. 19.1981 / No. 8
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r
Fig. 2. Stalagmometer used for lipase activity determination (from I.e. (66)). Lipase action on tributyrin reduces surface tension,
measured as drops/min. a: after/. Traube\ b: afterRona&.Michaelis.
enzymes of glycolysis in the blood serum of tumour rats
(3). This followed the development, during the preceding
years, of the necessary methodical tools, in particular
the "optical test" for the kinetic determination of
enzyme activities (3).
Determination of Enzyme Activities
as a Quantifying Diagnostic Method
At this point, I propose not to follow up the rapid
development, which set in after the second World War,
and which has led to the prominent position of enzyme
activity determination in today's clinical chemistry. In-
stead it would seem worthwile to consider more general
aspects and to look into the question of how the con-
cept of quantitative measurement of enzyme activity
developed and how it found acceptance in the world of
clinical medicine.
Rothschuh & Bleker (52) have pointed out that scientific
measuring methods were not introduced into clinical
diagnostics until about the 2nd half of the 19th century;
and this mainly under the influence of the physical
school of thought in physiology, evolving from 1840
and marked by names such as Brücke, Helmholtz, du
Bois-Reymond, Ludwig, and Vierordt. We should
mention here, e.g. the measurement of pulse frequency,
blood pressure, body temperature; also the methods of
spirometry and blood cell counting, and the quantita-
tive techniques of ophthalmology.
At that time, considerable difficulties, both theoretical
and practical, were still standing in the way of quantifying
enzyme activities for clinical purposes.
First it was necessary to define the term "enzyme activ-
ity" exactly. Berzelius (2), in 1836, had spoken of
"Katalytische Kraft" (catalytic force), a term to be
found in textbooks even after the second World War,
whereas Sckwann (53) coined the term "metabolische
Kraft" (metabolic force). InHoppe-Seyler's textbook
of 1883 (54) one even finds "Energie der Verdauung"
(energy of digestion). Such rather vague terminology
was bound to make impossible an adequate definition
of a system of measurement.
It is worth noting that around the mid 19th century
there was still a complete lack of tools on the part of
chemistry. Chemists, in the words of Edmund Farber
(55), "were late in developing time-consciousness".
After Wilhelmy's classic work about the Jaw of time in
cane sugar inversion by acids (1851) (56), though un-
noticed at the time, it was M. Berthelot (1862) (57)
who first studied the measurement of reaction velocities.
But it was the newly developing physical chemistry,
under Ostwald, van'tHoff,Arrhenius, and others, that
produced a kinetic theory of reactions, thus also creating
the basis for the study of catalytic and enzymatic reac-
tions.
Meanwhile, in connection with the study of "digestive
ferments", the first experiments had been carried out
on the quantification of enzyme action. Such experiments
were needed for a comparison between different enzyme
preparations (e.g. pepsin (7)).
The most careful experiments in the early days were
undertaken by Bidder & Schmidt in Dorpat (1852) (58),
who used cylinders of coagulated egg albumin, and
determine'd their decrease in weight under the influence
of pepsin. The principle of series dilution of enzyme solu-
tions became widely used; for instance, in Wohlgemutes
method, mentioned earlier, for diastase determination
(31).
J. Clin. Chem. Clin. Biochem. / Vol. 19,1981 / No. 8
Büttner: Evolution of clinical enzymology 535
Initially, the study of the kinetics of enzyme reactions
produced inconsistent results. This was discussed by
Wilhelm Ostwald in his paper "Über Katalyse" at the
1901 "Naturforscherversammlung" (59). Thus, certain
studies gave rise to doubts whether enzyme reactions
were, like other catalytic reactions, subject to the law of
mass action.
'Sullivan & Tompson (60), A. Brown (61), Henry (62),
and finally Michaelis &Menten (63), in a series of very
careful studies on invertase, whose activity was easy to
monitor polarimetrically, succeeded in deriving exact
rate equations, which ultimately led to the really con-
structive concept of the enzyme-substrate intermediate.
It then also became possible to define quantities for
enzyme activity based on enzyme kinetic measurements.
Initially, however, these were only used for a characteriza-
tion of purified enzyme preparations. For clinical
enzyme activity determinations, recourse was taken to a
definition of arbitrary units, which quickly grew into an
immense variety. Worldwide standardization was reached
as late as in 1961, when the International Enzyme Unit
was introduced (64).
The importance of test conditions for the measuring of
enzyme activities had meanwhile become apparent. One
had learnt to define the reaction temperature, pH, sub-
strate concentration, etc., as the basis for achieving
consistent results. The work of Michaelis &Menten (63)
had proved that it was possible to measure enzyme
activities with an excess of substrate as zero-order reac-
tions at maximum reaction velocities. Finally, from
1935 onwards, with the development of the universally
applicable principle of the optical test by Otto Warburg
(3), and with the advent of suitable photometers, the
theoretical and practical requirements existed for using
that complex measuring quantity, "enzyme activity", in
clinical chemistry; that is, for carrying out determina-
tions of enzyme activities in addition to the traditional
determinations of concentrations.
Widespread reception by the clinical world became
possible from about the end of the second World War,
after workable pathophysiological concepts had become
available for clinical use; e.g. for pancreatic enzymes,
phosphatases, cell enzymes.
Robert E. Köhler (65) has pointed out that modern
dynamic biochemistry came into being at the same time
as, and in connection with, enzymology (or the enzyme
theory or life). To me it would seem that a similar con-
nection exists between modern clinical chemistry and
clinical enzymology. Clinical chemistry has discovered
the "dimension of time"; it has acquired an aspect of
dynamics, following the evolution of clinical enzymology
in its midst.
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